Hemmie Chang, head of Arnold & Porter’s newly launched Boston office, is a leading lawyer in the life sciences industry. Inducted into the LMG Life Sciences Hall of Fame, she is an experienced advisor with a keen and strategic business sense, combined with her deep substantive knowledge and legal acumen. Hemmie regularly advises life sciences companies on high-profile intellectual property transactions, finding creative solutions for their complex needs, and helping them navigate the legal landscape as they develop their innovative IP and look to commercialize it globally. In recent years, Hemmie has closed more than $20 billion in deals across diverse therapeutic areas on behalf of such clients as AcuraStem, April Bio, Alexion*, Applied Genetic Technologies*, Daewoong, Dicerna*, Genevant*, H.I.G. Capital*, LigaChem Biosciences, Phenomic AI and Tiger Management*. *Experience at prior firm.